---
figid: PMC6990905__ijbsv16p0529g008
figlink: pmc/articles/PMC6990905/figure/F8/
number: F8
caption: Proposed mechanism of UA reduction by empagliflozin. Empagliflozin treatment
  improved hyperuricemia by promoting UA excretion through up-regulating ABCG2 expression
  in diabetes with hyperuricemia. Furthermore, empagliflozin treatment promoted the
  phosphorylation of AMPK, AKT and CREB and further activated ABCG2 by facilitating
  CREB binding to the promoter of ABCG2 to induce transcription.
pmcid: PMC6990905
papertitle: Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB
  Signaling Pathway in Type 2 Diabetic Mice.
reftext: Yun-hong Lu, et al. Int J Biol Sci. 2020;16(3):529-542.
pmc_ranked_result_index: '86945'
pathway_score: 0.953966
filename: ijbsv16p0529g008.jpg
figtitle: UA reduction by empagliflozin
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6990905__ijbsv16p0529g008.html
  '@type': Dataset
  description: Proposed mechanism of UA reduction by empagliflozin. Empagliflozin
    treatment improved hyperuricemia by promoting UA excretion through up-regulating
    ABCG2 expression in diabetes with hyperuricemia. Furthermore, empagliflozin treatment
    promoted the phosphorylation of AMPK, AKT and CREB and further activated ABCG2
    by facilitating CREB binding to the promoter of ABCG2 to induce transcription.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - AKT2
  - AKT3
  - AKT1
  - ATF2
  - CREB5
  - CREB3
  - CREB3L3
  - ATF1
  - CREB1
  - CREM
  - CREB3L2
  - CREB3L1
  - CREB3L4
  - ABCG2
  - Empagliflozin
  - uric acid
  - Diabetes
  - hyperuricemia
genes:
- word: p-AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: p-AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: p-AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: p-AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: p-AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: p-AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: p-AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: р-АКT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: р-АКT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: р-АКT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: p-CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: -CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: ABCG2
  symbol: ABCG2
  source: hgnc_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: АВСG2
  symbol: ABCG2
  source: hgnc_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
chemicals:
- word: Empagliflozin
  source: MESH
  identifier: C570240
- word: uric acid
  source: MESH
  identifier: D014527
diseases:
- word: Diabetes
  source: MESH
  identifier: D003920
- word: hyperuricemia
  source: MESH
  identifier: D033461
figid_alias: PMC6990905__F8
redirect_from: /figures/PMC6990905__F8
figtype: Figure
---
